Company profile

Fuzhou minhai pharmaceutical co. LTD was established in 1999 with a total investment of 120 million yuan and a registered capital of 12.8 million yuan. It is a state-level high-tech enterprise integrating R&D, production and sales. It is located in the famous hometown of overseas Chinese in Fujian Province. - Fuyang City Jingyang Industrial Zone, with a number of production lines such as Chinese and Western medicine tablets, capsules, granules.

The company has hundreds of employees and a quarter of professionals with intermediate and senior technical titles. The main products are digestive system medication: pantoprazole sodium enteric-coated capsules; cardio-cerebral vascular medication: Danqi capsule, Danqi tablets;  Yinao capsule, Xingnao Reconstruction capsule; orthopedics medication: jumping bone Three series of more than forty varieties, including tablets, wounds, anti-bone and three-seven tablets; among them, "Yinnao Capsule" and "Xingnao Reconstruction Capsule" are listed as national Chinese medicine protection varieties, The sodium azole sodium enteric-coated capsule is a proton pump-inhibiting stomach medicine, and has been firmly in the forefront of the sales of similar products in the country for many years. The company has established long-term good strategic cooperative relations with many well-known pharmaceutical companies such as China Resources, Guokong, Huayuan and Jiuzhoutong. The products are widely used in more than 1,000 secondary hospitals. Currently, the company is actively expanding the international market. Banlangen granules It has been sold to Canada in 2016.

Bohai Pharmaceutical has always been committed to building a technological innovation project based on the combination of production, learning and research. The company has long-term cooperation with many famous domestic universities and research institutes such as China Pharmaceutical University, Shenyang Pharmaceutical University, Peking University Medical College, China Academy of Chinese Medical Sciences, etc., and employs experts in medicinal chemistry, pharmaceutical preparations, clinical pharmacy as consultants. Over the years, it has won “Provincial Enterprise Technology Center”, “Key High-tech Enterprise”, “Fujian Province Science and Technology Little Giant Leading Enterprise”, “3A Credit Enterprise”, “Integrity Management Advanced Unit”, “Fuzhou Excellent Entrepreneur”, etc. Honor. The company has applied for 40 patents and 30 authorized patents. Among them, the fluidized bed coating technology pantoprazole sodium enteric-coated pellets project won the national Torch Program project certificate. At present, the company is developing a new class of 3 drugs, which has completed the BE test. The new drug is the only anti-acidic drug in the world that is used to prevent aspiration pneumonia before surgery. It can be used for the treatment of various stomach diseases in adults and children.

Customer trust, employee love, social recognition, and industry esteem are the unswerving pursuit goals of Bohai Pharmaceutical. Scientific management, enterprising innovation, pursuit of quality, and customer first are the quality policy that Bohai Pharmaceutical adheres to. For 20 years, quality The products have won unanimous praise and praise from customers and drug regulatory departments, and have gradually established a good brand image throughout the country. The “Bohai” brand has been recognized as a famous trademark in Fujian Province.

20 years of enterprise accumulation, 20 years of advancing with the times, Bohai people diligent dedication, unity and hard work, to protect health and life and strive for excellence! Bohai Pharmaceutical, for health, make medicine!